Atlas Trials

MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer

Clinical trial NCT00799240 · COMPLETED

Trial details

NCT number
NCT00799240
Sponsor
University of Kansas
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non Small Cell Lung Cancer
Start date
2009-06-01
Primary completion
2011-02-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.